What AIDS is teaching us about COVID-19
SAN JOSE, Calif. — Even as the deadly virus spread, the federal response stalled. Tests were short. So were treatments. A vaccine was imminent, experts promised. The hardest hit? The sick, the poor and people of color.That pathogen was HIV, not COVID-19. The year was 1990, not 2020. The event: The International AIDS Conference, held in San Francisco – which is again sponsoring the megaevent, virtually, this week.“These are the same challenges we’re facing now,” said Ernest Hopkins, senior strategist and adviser to The San Francisco AIDS Foundation. “The similarities are profound.”The twin pand...
The Mercury News
HIV drug patients' privacy violated by Gilead, lawsuit claims
PHILADELPHIA — A drug company may have violated the privacy of thousands of people who are taking a medicine to prevent them from coming down with HIV.Gilead Sciences, the biopharmaceutical giant, sent out a mass mailing in mid-April to people on its antiretroviral drugs, Truvada and Descovy. The drugs are used to reduce the risk of HIV infection, a prevention measure called pre-exposure prophylaxis (PrEP).On Thursday, the AIDS Law Project of Pennsylvania filed a federal class action suit against Gilead. It claims the company illegally compromised the privacy rights of patients by recklessly m...
The Philadelphia Inquirer